Le Journal des biotechs : Frédéric Gomez (Pharmium Securities), Mathieu Charvériat THX Pharma)

from Le Journal des Biotechs · host BOURSORAMA

Dans ce numéro du Journal des biotechs, l'analyste biotech Frédéric Gomez revient sur les progressions boursières du moment avec Medincell (/cours/1rPMEDCL/)et Nanobiotix (/cours/1rPNANO/). Il analyse également la situation de Novo Nordisk et livre son coup de cœur sur Genmab.L'entretien est consacré à THX Pharma. Son PDG Mathieu Charvériat revient sur les derniers développements en cous de la biotech.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published Oct 27, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Le Journal des biotechs : Frédéric Gomez (Pharmium Securities), Mathieu Charvériat THX Pharma)

0:00 29:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 29 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on October 27, 2025.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!